Skip to main content
Top
Published in: Virology Journal 1/2023

Open Access 01-12-2023 | Diarrhea | Research

Vector-delivered artificial miRNA effectively inhibits Porcine epidemic diarrhea virus replication

Authors: Tingfan Zhu, Jinhan Qian, Zijun Shen, Hongxia Shao, Kun Qian, Wenjie Jin, Aijian Qin

Published in: Virology Journal | Issue 1/2023

Login to get access

Abstract

Background

Porcine epidemic diarrhea virus (PEDV) is an α-coronavirus that causes highly contagious intestinal infectious disease, involving clinically characterized by diarrhea, dehydration, vomiting, and high mortality to suckling piglets. As a strategy for antiviral therapy, artificial microRNA (amiRNA) mediated suppression of viral replication has recently become increasingly important. In this study, we evaluated the advantages of using an amiRNA vector against PEDV.

Methods

In this study, we evaluated the advantages of using an amiRNA vector against PEDV. We designed two single amiRNA sequences for different conserved sequences of the PEDV S and N genes, and tested their inhibitory effects on PEDV in Vero cells.

Results

It was obvious from the CCK-8 results that the transient transfection of amiRNA was non-toxic to the cells. In addition, our results showed that the transient expression of two amiRNAs (amiRNA-349 and amiRNA-1447) significantly reduced the expression of viral RNA and protein in the cells. The TCID50 results showed that the release of virus particles into the culture supernatant was significantly reduced, with an effect as high as 90%. To avoid virus mutation escape, the above two single amiRNA sequences were tandem in this study (amiRNA-349 + 1447), enabling a single microRNA to be expressed simultaneously. The real-time PCR and Western blot results showed that the inhibitory effect was significantly enhanced in each of the different time periods. The TCID50 results showed that the release of virus particles in the culture supernatant was significantly reduced at the different time periods.

Conclusions

In summary, these results suggest that an RNAi based on amiRNA targeting the conserved region of the virus is an effective method to improve PEDV nucleic acid inhibitors and provide a novel treatment strategy for PEDV infection.
Literature
1.
go back to reference Song D. Park BJ. Porcine epidemic diarrhoea virus: a comprehensive review of molecular epidemiology, diagnosis, and vaccines. Virus Genes. 2012;44:167–75.CrossRefPubMedPubMedCentral Song D. Park BJ. Porcine epidemic diarrhoea virus: a comprehensive review of molecular epidemiology, diagnosis, and vaccines. Virus Genes. 2012;44:167–75.CrossRefPubMedPubMedCentral
2.
go back to reference Have P, Moving V, Svansson V, Uttenthal Å, Bloch BJ. Coronavirus infection in mink (Mustela vision). Serological evidence of infection with a coronavirus related to transmissible gastroenteritis virus and porcine epidemic diarrhea virus. Vet Microbiol. 1992;31:1–10.CrossRefPubMedPubMedCentral Have P, Moving V, Svansson V, Uttenthal Å, Bloch BJ. Coronavirus infection in mink (Mustela vision). Serological evidence of infection with a coronavirus related to transmissible gastroenteritis virus and porcine epidemic diarrhea virus. Vet Microbiol. 1992;31:1–10.CrossRefPubMedPubMedCentral
3.
go back to reference Pijpers A, Van Nieuwstadt A, Terpstra C, Verheijden JJ. Porcine epidemic diarrhoea virus as a cause of persistent diarrhoea in a herd of breeding and finishing pigs. Vet Rec. 1993;132:129–31.CrossRefPubMed Pijpers A, Van Nieuwstadt A, Terpstra C, Verheijden JJ. Porcine epidemic diarrhoea virus as a cause of persistent diarrhoea in a herd of breeding and finishing pigs. Vet Rec. 1993;132:129–31.CrossRefPubMed
4.
go back to reference Martelli P, Lavazza A, Nigrelli A, Merialdi G, Alborali L, Pensaert MJ. Epidemic of diarrhoea caused by porcine epidemic diarrhoea virus in Italy. Vet Record. 2008;162:307–10.CrossRefPubMed Martelli P, Lavazza A, Nigrelli A, Merialdi G, Alborali L, Pensaert MJ. Epidemic of diarrhoea caused by porcine epidemic diarrhoea virus in Italy. Vet Record. 2008;162:307–10.CrossRefPubMed
5.
go back to reference Tan YW, Fang S, Fan H, Lescar J, Liu DJ. Amino acid residues critical for RNA-binding in the N-terminal domain of the nucleocapsid protein are essential determinants for the infectivity of coronavirus in cultured cells. Nucleic Acids Res. 2006;34:4816–25.CrossRefPubMedPubMedCentral Tan YW, Fang S, Fan H, Lescar J, Liu DJ. Amino acid residues critical for RNA-binding in the N-terminal domain of the nucleocapsid protein are essential determinants for the infectivity of coronavirus in cultured cells. Nucleic Acids Res. 2006;34:4816–25.CrossRefPubMedPubMedCentral
6.
go back to reference Bosch BJ, Van der Zee R, De Haan CA, Rottier PJ. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol. 2003;77:8801–11.CrossRefPubMedPubMedCentral Bosch BJ, Van der Zee R, De Haan CA, Rottier PJ. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol. 2003;77:8801–11.CrossRefPubMedPubMedCentral
7.
go back to reference Chen Y, Zhang Z, Li J, Gao Y, Zhou L, Ge X, Han J, Guo X, Yang HJ. Porcine epidemic diarrhea virus S1 protein is the critical inducer of apoptosis. Virol J. 2018;15:1–11.CrossRefPubMedPubMedCentral Chen Y, Zhang Z, Li J, Gao Y, Zhou L, Ge X, Han J, Guo X, Yang HJ. Porcine epidemic diarrhea virus S1 protein is the critical inducer of apoptosis. Virol J. 2018;15:1–11.CrossRefPubMedPubMedCentral
8.
9.
go back to reference Elbashir SM, Lendeckel W, Tuschl TJ. Development: RNA interference is mediated by 21-and 22-nucleotide RNAs. Genes. 2001;15:188–200.CrossRef Elbashir SM, Lendeckel W, Tuschl TJ. Development: RNA interference is mediated by 21-and 22-nucleotide RNAs. Genes. 2001;15:188–200.CrossRef
10.
go back to reference Ely A, Naidoo T, Mufamadi S, Crowther C, Arbuthnot PJ. Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo. Mol Ther. 2008;16:1105–12.CrossRefPubMed Ely A, Naidoo T, Mufamadi S, Crowther C, Arbuthnot PJ. Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo. Mol Ther. 2008;16:1105–12.CrossRefPubMed
11.
go back to reference McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, Martins I, Gilmore BL, Burstein H, Peluso RW. Polisky BJ. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad. 2008;105:5868–73.CrossRef McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, Martins I, Gilmore BL, Burstein H, Peluso RW. Polisky BJ. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad. 2008;105:5868–73.CrossRef
12.
go back to reference Boudreau RL, Martins I, Davidson BL. Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo. Mol Ther. 2009;17:169–75.CrossRefPubMed Boudreau RL, Martins I, Davidson BL. Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo. Mol Ther. 2009;17:169–75.CrossRefPubMed
13.
go back to reference Zhang T, Cheng T, Wei L, Cai Y, Yeo AE, Han J, Yuan YA, Zhang J, Xia N. Efficient inhibition of HIV-1 replication by an artificial polycistronic miRNA construct. Virol J. 2012;9:1–11.CrossRef Zhang T, Cheng T, Wei L, Cai Y, Yeo AE, Han J, Yuan YA, Zhang J, Xia N. Efficient inhibition of HIV-1 replication by an artificial polycistronic miRNA construct. Virol J. 2012;9:1–11.CrossRef
14.
go back to reference Su M, Li C, Qi S, Yang D, Jiang N, Yin B, Guo D, Kong F, Yuan D, Feng L. A molecular epidemiological investigation of PEDV in China: characterization of co-infection and genetic diversity of S1-based genes. Transbound Emerg Diseases. 2020;67:1129–40.CrossRef Su M, Li C, Qi S, Yang D, Jiang N, Yin B, Guo D, Kong F, Yuan D, Feng L. A molecular epidemiological investigation of PEDV in China: characterization of co-infection and genetic diversity of S1-based genes. Transbound Emerg Diseases. 2020;67:1129–40.CrossRef
15.
go back to reference Sun R-Q, Cai R-J, Chen Y-Q, Liang P-S, Chen D-K, Song C-X. Outbreak of porcine epidemic diarrhea in suckling piglets, China. Emerg Infect Diseases. 2012;18:161.CrossRef Sun R-Q, Cai R-J, Chen Y-Q, Liang P-S, Chen D-K, Song C-X. Outbreak of porcine epidemic diarrhea in suckling piglets, China. Emerg Infect Diseases. 2012;18:161.CrossRef
16.
go back to reference Tian P-F, Jin Y-L, Xing G, Qv L-L, Huang Y-W, Zhou J-Y. Evidence of recombinant strains of porcine epidemic diarrhea virus, United States, 2013. Emerg Infect Dis. 2014;20:1735.CrossRefPubMedPubMedCentral Tian P-F, Jin Y-L, Xing G, Qv L-L, Huang Y-W, Zhou J-Y. Evidence of recombinant strains of porcine epidemic diarrhea virus, United States, 2013. Emerg Infect Dis. 2014;20:1735.CrossRefPubMedPubMedCentral
17.
go back to reference Alonso C, Goede DP, Morrison RB, Davies PR, Rovira A, Marthaler DG, Torremorell M. Evidence of infectivity of airborne porcine epidemic diarrhea virus and detection of airborne viral RNA at long distances from infected herds. Vet Res. 2014;45:1–5.CrossRef Alonso C, Goede DP, Morrison RB, Davies PR, Rovira A, Marthaler DG, Torremorell M. Evidence of infectivity of airborne porcine epidemic diarrhea virus and detection of airborne viral RNA at long distances from infected herds. Vet Res. 2014;45:1–5.CrossRef
18.
go back to reference Kwon H-J, Ryu YB, Kim Y-M, Song N, Kim CY, Rho M-C, Jeong J-H, Cho K-O, Lee WS. Park S-J. In vitro antiviral activity of phlorotannins isolated from Ecklonia cava against porcine epidemic diarrhea coronavirus infection and hemagglutination. Bioorg Med Chem. 2013;21:4706–13.CrossRefPubMedPubMedCentral Kwon H-J, Ryu YB, Kim Y-M, Song N, Kim CY, Rho M-C, Jeong J-H, Cho K-O, Lee WS. Park S-J. In vitro antiviral activity of phlorotannins isolated from Ecklonia cava against porcine epidemic diarrhea coronavirus infection and hemagglutination. Bioorg Med Chem. 2013;21:4706–13.CrossRefPubMedPubMedCentral
19.
go back to reference Stevenson GW, Hoang H, Schwartz KJ, Burrough ER, Sun D, Madson D, Cooper VL, Pillatzki A, Gauger P, Schmitt BJ. Emergence of porcine epidemic diarrhea virus in the United States: clinical signs, lesions, and viral genomic sequences. J Vet Diagn Invest. 2013;25:649–54.CrossRefPubMed Stevenson GW, Hoang H, Schwartz KJ, Burrough ER, Sun D, Madson D, Cooper VL, Pillatzki A, Gauger P, Schmitt BJ. Emergence of porcine epidemic diarrhea virus in the United States: clinical signs, lesions, and viral genomic sequences. J Vet Diagn Invest. 2013;25:649–54.CrossRefPubMed
20.
go back to reference Baek P-S, Choi H-W, Lee S, Yoon I-J, Lee YJ, Lee S, Lee C. Efficacy of an inactivated genotype 2b porcine epidemic diarrhea virus vaccine in neonatal piglets. Vet Immunol. 2016;174:45–9.CrossRef Baek P-S, Choi H-W, Lee S, Yoon I-J, Lee YJ, Lee S, Lee C. Efficacy of an inactivated genotype 2b porcine epidemic diarrhea virus vaccine in neonatal piglets. Vet Immunol. 2016;174:45–9.CrossRef
21.
go back to reference Hou Y, Meulia T, Gao X, Saif LJ, Wang QJ. Deletion of both the tyrosine-based endocytosis signal and the endoplasmic reticulum retrieval signal in the cytoplasmic tail of spike protein attenuates porcine epidemic diarrhea virus in pigs. J Virol. 2019;93:e01758-e11718.CrossRefPubMedPubMedCentral Hou Y, Meulia T, Gao X, Saif LJ, Wang QJ. Deletion of both the tyrosine-based endocytosis signal and the endoplasmic reticulum retrieval signal in the cytoplasmic tail of spike protein attenuates porcine epidemic diarrhea virus in pigs. J Virol. 2019;93:e01758-e11718.CrossRefPubMedPubMedCentral
22.
go back to reference Zhao P, Wang B, Ji C-M, Cong X, Wang M, Huang Y-W. Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies. Antiviral Res. 2018;150:1–8.CrossRefPubMed Zhao P, Wang B, Ji C-M, Cong X, Wang M, Huang Y-W. Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies. Antiviral Res. 2018;150:1–8.CrossRefPubMed
23.
go back to reference Yin Y, Zhu L, Liu P, Zhao J, Fan Y, Sun X, Xu Z. Evaluation on the efficacy and immunogenicity of recombinant DNA plasmids expressing S gene from porcine epidemic diarrhea virus and VP7 gene from porcine rotavirus. Braz J Microbiol. 2019;50:279–86.CrossRefPubMed Yin Y, Zhu L, Liu P, Zhao J, Fan Y, Sun X, Xu Z. Evaluation on the efficacy and immunogenicity of recombinant DNA plasmids expressing S gene from porcine epidemic diarrhea virus and VP7 gene from porcine rotavirus. Braz J Microbiol. 2019;50:279–86.CrossRefPubMed
24.
25.
go back to reference Saha A, Bhagyawant SS, Parida M, Dash PK. Vector-delivered artificial miRNA effectively inhibited replication of Chikungunya virus. Antiviral Res. 2016;134:42–9.CrossRefPubMedPubMedCentral Saha A, Bhagyawant SS, Parida M, Dash PK. Vector-delivered artificial miRNA effectively inhibited replication of Chikungunya virus. Antiviral Res. 2016;134:42–9.CrossRefPubMedPubMedCentral
26.
go back to reference Gao Y-F, Yu L, Wei W, Li J-B, Luo Q-L, Shen J. Inhibition of hepatitis B virus gene expression and replication by artificial microRNA. World J Gastroenterol: WJG. 2008;14:4684.CrossRefPubMedPubMedCentral Gao Y-F, Yu L, Wei W, Li J-B, Luo Q-L, Shen J. Inhibition of hepatitis B virus gene expression and replication by artificial microRNA. World J Gastroenterol: WJG. 2008;14:4684.CrossRefPubMedPubMedCentral
27.
go back to reference Bhomia M, Sharma A, Gayen M, Gupta P, Maheshwari RKJ. Artificial microRNAs can effectively inhibit replication of Venezuelan equine encephalitis virus. Antiviral Res. 2013;100:429–34.CrossRefPubMedPubMedCentral Bhomia M, Sharma A, Gayen M, Gupta P, Maheshwari RKJ. Artificial microRNAs can effectively inhibit replication of Venezuelan equine encephalitis virus. Antiviral Res. 2013;100:429–34.CrossRefPubMedPubMedCentral
28.
go back to reference Xie P-w, Xie Y, Zhang X-j, Huang H, He L-n, Wang X-j, Wang S-q. Inhibition of dengue virus 2 replication by artificial micrornas targeting the conserved regions. Nucleic Acid Therap. 2013;23:244–52.CrossRef Xie P-w, Xie Y, Zhang X-j, Huang H, He L-n, Wang X-j, Wang S-q. Inhibition of dengue virus 2 replication by artificial micrornas targeting the conserved regions. Nucleic Acid Therap. 2013;23:244–52.CrossRef
29.
go back to reference Karothia D, Dash PK, Parida M, Bhagyawant SS, Kumar JSJ. Vector derived artificial miRNA mediated inhibition of West Nile virus replication and protein expression. Gene. 2020;729:144300.CrossRefPubMed Karothia D, Dash PK, Parida M, Bhagyawant SS, Kumar JSJ. Vector derived artificial miRNA mediated inhibition of West Nile virus replication and protein expression. Gene. 2020;729:144300.CrossRefPubMed
Metadata
Title
Vector-delivered artificial miRNA effectively inhibits Porcine epidemic diarrhea virus replication
Authors
Tingfan Zhu
Jinhan Qian
Zijun Shen
Hongxia Shao
Kun Qian
Wenjie Jin
Aijian Qin
Publication date
01-12-2023
Publisher
BioMed Central
Keywords
Diarrhea
Diarrhea
Published in
Virology Journal / Issue 1/2023
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-023-02129-5

Other articles of this Issue 1/2023

Virology Journal 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.